- Rating
- 2
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
This paper proposes ScComp, a framework for predicting spatial gene expression from H&E histology. ScComp predicts composition weights over a fixed single-cell reference matrix and combines the reference profiles to obtain a reference component of the predicted expression. A reference-orthogonal residual captures additional expression variation outside the space spanned by the reference profiles.
Critical strengths
- The paper presents a complete framework for histology-to-spatial-transcriptomics prediction, with evaluation across three patient-disjoint benchmarks. ScComp achieves strong predictive performance with a relatively small number of trainable parameters.
- The learned composition weights can be reused to predict reference-covered genes outside the training gene panel. The gene- and pathway-level evaluations provide useful evidence of this capability.
Critical weaknesses
- The overall narrative could be clearer and more focused. The introduction is somewhat lengthy, while the methodological novelty is not explained in sufficient depth. In particular, the distinction from existing single-cell reference-informed prediction methods could be articulated more explicitly.
- The motivation for the residual component is not sufficiently clear. The description suggests that it captures biologically meaningful expression variation not represented by the reference, but the paper does not establish which specific biological situations this component addresses. The evidence primarily supports its role as a mathematical correction constrained to the orthogonal complement of the reference space. A clearer distinction between this mathematical role and its possible biological interpretation would make the motivation easier to understand.
Questions for authors
- Could the authors explain more explicitly what constitutes the “single-cell reference”? In particular, please clarify what each reference profile represents and how these profiles are constructed and used to predict spot-level expression.
- Could the authors clarify what variation the reference space can represent and what its limitations are? A concrete example of expression variation that cannot be represented by the reference component would help explain the need for the residual and the rationale for the orthogonal constraint.
4 comments
W1. The overall narrative could be clearer and more focused. The introduction is somewhat lengthy, while the methodological novelty is not explained in sufficient depth. In particular, the distinction from existing single-cell reference-informed prediction methods could be articulated more explicitly.
Q2 & W2. Could the authors clarify what variation the reference space can represent and what its limitations are? A concrete example of expression variation that cannot be represented by the reference component would help explain the need for the residual and the rationale for the orthogonal constraint.
Reference-based prediction and its limitations. The reference consists of a finite set of donor-averaged profiles and may not capture all expression patterns in a tissue. For example, breast tumors exhibit patient-associated malignant expression patterns and distinct fibroblast states, illustrating variation that average reference profiles may not fully represent (Wu et al., 2021).
Residual and orthogonal constraint. To account for expression variation outside the reference space, ScComp introduces a residual component. Without an orthogonal constraint, the residual could reproduce expression patterns already represented by the reference, making it unclear which component explains a given signal. We therefore constrain the residual to the orthogonal complement of the row space of . This ensures that the residual is orthogonal to every reference profile and to (Eqs. 8–10), preventing it from duplicating reference-aligned expression patterns. The final prediction combines the reference component, a learned gene-wise bias, and the orthogonal residual.
Appendix I provides concrete spatial examples (lines 965–970; Figure 4). For COL1A2 in HER2ST section B5, PCC increases from −0.01 for the reference component to 0.68 for the final prediction. The corresponding improvements are 0.06 to 0.72 for KRT16 in cSCC section P2_ST_rep2 and 0.06 to 0.83 for EVL in STNet section BC23287_D1. These examples show spatial expression patterns that the reference component captures poorly and that the final prediction captures more accurately after adding the residual.
Distinction from existing methods. SciSt combines a single-cell-based expression estimate with learned image features, whereas CPNN updates its reference profiles during training. In contrast, ScComp keeps the reference fixed and constrains the residual to its orthogonal complement. This maintains a consistent correspondence between the predicted weights and the original reference profiles while modeling additional expression variation separately.
These properties support two capabilities demonstrated in our experiments: the predicted weights correlate with Xenium-derived cell-type proportions without composition supervision (Sec. 4.4), and they can be used to predict reference-covered genes outside the training panel without additional training (Sec. 4.3).
We have clarified the motivation and complementary roles of the fixed single-cell reference and the orthogonal residual in the Introduction (lines 067–074). We have also made the distinction from SciSt and CPNN explicit in Sec. 2.2, explaining how the fixed reference and orthogonal residual preserve the correspondence between the weights and the original reference profiles (lines 132–138). Concrete spatial examples are provided in Appendix I (lines 965–970; Figure 4).
I thank the authors for their response and revisions, which have improved the manuscript to some extent. However, substantial concerns remain that, in my view, cannot be adequately addressed within the rebuttal period. I encourage the authors to further develop and revise the manuscript before resubmission.
-
The proposed residual formulation primarily constitutes a mathematical contribution, and its justification focuses largely on improvements in predictive performance. Its biological significance has not been sufficiently established. This concern partly reflects how the manuscript motivates and presents the method.
-
The figures and the narrative structure of the Introduction still lack clarity. Beyond the residual formulation, the manuscript does not clearly articulate other compelling contributions. Since the residual formulation is primarily a mathematical operation, its novelty alone appears insufficient to support the overall contribution.
-
I encourage the authors to develop a more biologically grounded motivation, strengthen the methodological contributions, and provide more direct validation of the proposed formulation’s potential biological significance. A substantially revised Introduction and clearer figures would also help communicate the contribution more effectively.
We thank the reviewer for the follow-up comments and for recognizing the improvements in the manuscript. We also appreciate that the initial review acknowledged the evidence for predictive performance, parameter efficiency, and prediction beyond the training gene panel. The comments helped us explain the role of the residual within the overall framework more clearly.
Our contribution is the combination of reusable, cell-type-associated reference weights and an orthogonal residual that complements their predictive capacity. Cell composition describes which cells are present and in what proportions, but it does not fully describe expression differences among cells of the same type. To test whether the residual complements prediction of these differences, we used Xenium measurements to split the expression of each tile into the part expected from cell-type counts and within-section mean profiles (the composition component) and the remainder (the within-type component). The analysis is performed at the level of 13 cell types.
Adding the residual increases the PCC with the within-type component from 0.170 to 0.257. The full model also exceeds a model trained separately without a residual (0.201), and both comparisons improve in all 12 evaluated donors (p < 0.001). The increase for the composition component is not significant (0.386 to 0.436, p = 0.11). These results support that the residual complements prediction of expression differences that are not captured by the expression expected from cell composition.
The gene-level results give these differences a biological context. Of the 308 evaluated gene–cell-type pairs, 78 improve significantly and one worsens. In luminal cells, 5 of the 17 evaluated Hallmark gene sets improve more than the remaining luminal genes. The largest effects are for E2F targets and G2M checkpoint, in which 15 of 19 and 14 of 17 genes improve significantly (q < 0.001 for both sets). In fibroblasts, four of the six evaluated ECM regulators improve significantly, including MMP11, which was first reported in stromal cells surrounding invasive breast carcinomas (PCC −0.20 to 0.38; Basset et al., 1990). These patterns connect the benefit of the residual to proliferation-related gene sets and to individual matrix-remodeling genes such as MMP11.
Together with the cell-type correspondence of the reference weights and their reuse for unseen genes and pathways, these results support the complementary value of the two components. We have added this analysis as Sec. 4.5 (lines [453–494], Figure 4) and provide the definitions, statistical procedures, and full results in Appendix K (Figures 7–8). We have also stated in the Introduction which expression differences the residual complements (lines [072–073, 083–085]). Figure and line numbers refer to the latest revision.
Reference
Basset, P., et al. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348(6303), 699–704. doi:10.1038/348699a0
We sincerely thank the reviewer for the careful review and constructive suggestions. For clarity, all changes in the revised manuscript are highlighted in blue. We address Q1 here and discuss W1 and Q2/W2 in the following comment.
Motivation and reference construction. In spot-based ST, each spot contains multiple cells, and its measured gene expression reflects their combined contributions. Single-cell RNA sequencing provides gene expression profiles for individual cell types and states, which can serve as a reference for estimating these contributions.
We construct the reference matrix S using publicly available single-cell data from the CZ CELLxGENE Census. Each row corresponds to a (normal-source or cancer-source, annotated cell type) pair and represents its average log-normalized expression profile. The source category describes the donor diagnosis and does not imply that every cancer-source cell is malignant.
We first average expression within each donor and then average equally across donors, preventing donors with more cells from dominating a profile (Eqs. 2–3; Appendix C). This yields 68 reference rows for the breast datasets and 76 for the skin dataset.
Reference-based prediction. Given the histology image of a spot and its local neighborhood, ScComp predicts nonnegative weights π that sum to one. Each weight corresponds to a reference profile, and the weighted combination πS produces the reference component of spot-level expression in log-normalized space.
The reference matrix remains fixed throughout training, so each predicted weight retains its association with the corresponding reference cell type or state. The final prediction combines this reference component with a learned gene-wise bias and an orthogonal residual, whose role we explain in the following comment.